Company intelligence / Profile preview

Stitches

Cambridge, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Stitch is a biotechnology company developing a platform for large-scale DNA writing and gene editing. The company's technology is designed to "stitch" together long sequences of DNA, enabling the creation of complex genetic circuits and the engineering of cells for therapeutic applications. By overcoming the limitations of current gene editing tools that are often restricted to small genetic changes, Stitch aims to facilitate the insertion of large, multi-gene payloads into the genome. This capability is intended to support the development of next-generation cell and gene therapies for a wide range of diseases.

Modalities: Gene therapyCell therapyDNA writing
Industry: Biotech

Beyond the preview

Go deeper on Stitches.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stitches.

Explore the full profile